MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$46.99 -0.09 (-0.19%)
Open Price: 47.20
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients